191 related articles for article (PubMed ID: 16293377)
1. Continuation of hormone replacement therapy in Slovenia: a prospective, randomized, controlled trial--1-year follow-up.
Franić D; Verdenik I; Meden-Vrtovec H; Svab I
Maturitas; 2006 May; 54(2):110-8. PubMed ID: 16293377
[TBL] [Abstract][Full Text] [Related]
2. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
Ushiroyama T; Ikeda A; Sakuma K; Ueki M
J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
[TBL] [Abstract][Full Text] [Related]
3. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
4. Compliance considerations with hormone replacement therapy.
Karakoç B; Erenus M
Menopause; 1998; 5(2):102-6. PubMed ID: 9689204
[TBL] [Abstract][Full Text] [Related]
5. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
[TBL] [Abstract][Full Text] [Related]
6. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
Haskell SG
J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
[TBL] [Abstract][Full Text] [Related]
7. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
Gambrell RD; Natrajan PK
Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
[TBL] [Abstract][Full Text] [Related]
8. Spanish post-menopausal women's viewpoints on hormone therapy.
Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
[TBL] [Abstract][Full Text] [Related]
9. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
[TBL] [Abstract][Full Text] [Related]
10. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
Bakken K; Eggen AE; Lund E
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
[TBL] [Abstract][Full Text] [Related]
11. Effects of postmenopausal hormone replacement therapy on body fat composition.
Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
[TBL] [Abstract][Full Text] [Related]
12. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
[TBL] [Abstract][Full Text] [Related]
13. Continuation of hormone replacement therapy after hysterectomy.
Domoney C; Studd JW; Mocroft A
Climacteric; 2003 Mar; 6(1):58-66. PubMed ID: 12725666
[TBL] [Abstract][Full Text] [Related]
14. [Hormone replacement therapy--women's expectations and fears].
Schultz-Zehden B
Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):180-8. PubMed ID: 10802891
[TBL] [Abstract][Full Text] [Related]
15. Changes in the use of Hormone Replacement Therapy in New Zealand following the publication of the Women's Health Initiative trial.
Bilgrami I; Blower K; Feng J; Stefanko G; Tan E
N Z Med J; 2004 Nov; 117(1206):U1175. PubMed ID: 15570344
[TBL] [Abstract][Full Text] [Related]
16. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
[TBL] [Abstract][Full Text] [Related]
17. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
18. No effect of HRT on health-related quality of life in postmenopausal women with heart disease.
Sherman AM; Shumaker SA; Sharp P; Reboussin DM; Kancler C; Walkup M; Herrington DM
Minerva Ginecol; 2003 Dec; 55(6):511-7. PubMed ID: 14676740
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy: aspects of bleeding problems and compliance.
Samsioe G
Int J Fertil Menopausal Stud; 1996; 41(1):11-5. PubMed ID: 8673151
[TBL] [Abstract][Full Text] [Related]
20. Women's awareness of, and attitudes towards, hormone replacement therapy: ethnic differences and effects of age and education.
Lydakis C; Kerr H; Hutchings K; Lip GY
Int J Clin Pract; 1998; 52(1):7-12. PubMed ID: 9536560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
